NEW YORK (GenomeWeb) – Pharmacogenomic testing firm AltheaDx today announced it has raised $30 million in Series C financing.

WuXi Healthcare Ventures led the round, joined by WuXi PharmaTech, Ally Bridge Group, and Alma Life Sciences.

AltheaDx said it would use the funds for prospective trials for its IDgenetix test portfolio, product enhancements, and other growth opportunities.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.